Down's syndrome screening in twin pregnancies by nuchal translucency measurement: Current concept

Minerva Ginecologica

Volumn 54, Issue 3, 2002, Pages 211-215

  Maymon, R ^b   Jauniaux, E ^a   Herman, A ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

^c NONE

Author keywords

Down syndrome, diagnosis; Down syndrome, ultrasonography; Neck, ultrasonography; Prenatal diagnosis; Twins

Indexed keywords

DOWN SYNDROME; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MULTIPLE PREGNANCY; NECK; PREGNANCY; PREGNANCY OUTCOME; REVIEW; TWINS;

DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; NECK; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY, MULTIPLE; TWINS; ULTRASONOGRAPHY, PRENATAL;

EID: 0036593480     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Oliviennes F, Kadhel P, Rufat P, Fanchin R, Fernandez H, Frydman R. Perinatal outcome of twin pregnancies obtained after in vitro fertilization: comparison with twin pregnancies obtained spontaneously or after ovarian stimulation. Fertil Steril 1996;66(1):105-9.
2. Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester using free β-hCG and PAPP-A combined with fetal nuchal translucency thickness. Prenat Diagn 2000;20:91-5.
3. Botting BJ, Macdonald Davies J, Macfarlane AJ. Recent trends in the incidence of multiple birth and associated mortality. Arch Dis Child 1987;62:941-50.
4. Cuckle H. Down's syndrome screening in twins. J Med Screening 1998;5:3-4.
5. Doyle PE, Beral V, Botting B, Wale CJ. Congenital malformations in twins in England and Wales. J Epidemiol Commun Health 1991;45(1):43-8.
6. Wald NJ, Cuckle H, Wu TS, George L. Maternal serum unconjugated oestriol and human chorionic gonadotropin levels in twin pregnancies: implications for screening for Down's syndrome. Br J Obstet Gynecol 1991;98(9):905-8.
7. Räty R, Virtanen A, Koskinen P, Laitinen P, Forsstrom J, Salonen R et al. Maternal midtrimester serum AFP and free β-hCG levels in in vitro fertilization twin pregnancies. Prenat Diagn 2000;20(3):221-3.
8. Pandya PP, Snijders RJM, Johnson SP, De Lourdes Brizot M, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995;102(12):957-62.
9. Snijders RJM, Noble PL, Sebire NJ, Souka A, Nicolaides KH. UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998;352(9125):343-6.
10. Szabo J, Gallen J. Nuchal fluid accumulation in trisomy 21 detected by vaginosonography in first trimester. Lancet 1990;336:1133.
11. Nicolaides KH, Sebire NJ, Snijders RJM. The 11-14 week scan: the diagnosis of fetal abnormalities. New York: Parthenon Publ . 1999.
12. Nicolaides KH, Snijders RJM, Cuckle HS. Correct estimation of parameters for ultrasound nuchal translucency screening. Prenat Diagn 1999;18:519-21.
13. Cuckle H. Antenatal screening. Semin Neonat 1998;3: 1-8.
14. Spencer K, Salonen R, Muller F. Down's syndrome screening in multiple pregnancies using α-fetoprotein and free β-hCG. Prenat Diagn 1994;14:537-42.
15. Wald N, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down's syndrome. J Med Screen 1997;4(4):181-246.
16. Pandya PP, Hilbert F, Snijders RJM, Nicolaides KH. Nuchal translucency thickness and crown-rump length in twin pregnancies with chromosomally abnormal fetuses. J Ultrasound Med 1995;14(8):565-8.
17. Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynecol 1996;103(10):999-1003.
18. Sebire NJ, Noble PL, Psarra A, Papapanagiotou G, Nicolaides KH. Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency. Br J Obstet Gynaecol 1996;103(9): 887-90.
19. Sebire NJ, D'Ercole C, Hughes K, Carvalho M, Nicolaides KH. Increased nuchal translucency thickness at 10-14 weeks of gestation as a prediction of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynaecol 1997;10(2):86-9.
20. Sebire NJ, Souka A, Skentou H, Geerts L, Nicolaides KH. Early prediction of severe twin-to-twin transfusion syndrome. Hum Reprod 2000;15(9):2008-10.
21. Maymon R, Dreazen E, Rozinsky S, Bukovsky I, Weinraub Z, Herman A. Comparison of nuchal translucency measurement and second trimester triple serum screening in twin versus singleton pregnancies. Prenat Diagn 1999;19:727-31.
22. Kidd SA, Lancaster PA, Anderson JC, Bogert A, Fisher CC, Robertson R et al. A cohort study of pregnancy outcome after amniocentesis in twin pregnancy. Paediatr Perinat Epidemiol 1997;11(2):200-13.
23. Wald W, Watt HC, Hackshaw AK. Integrated screening for Down syndrome based on tests performed during the first and second trimesters. N Engl J Med 1999;341: 461-7.
24. Cuckle H, Sehmi I. Calculating correct Down's syndrome risks. Br J Obstet Gynaecol 1996;106:371-2.
25. Cuckle H. Twins. Down's syndrome News 2001; 8(2):5.
26. Maymon R, Jauniaux E, Holmes A, Wiener YM, Dreazen E, Herman A. Nuchal translucency measurement and pregnancies outcomes after assisted conception versus spontaneously conceived twins. Hum Reprod 2001;16:1999-2004.
27. Herman A, Dreazen E, Samandarov A, Bukovsky I, Weinraub Z, Maymon R. On-to-on versus on-to-out nuchal translucency measurements. Ultrasound Obstet Gynaecol 2000;15:126-30.